A Double-Blind, Randomised, Clinical Trial of the Effect of Lurasidone on Body Fat and Metabolic Indices in Schizophrenia
Lurasidone is a new antipsychotic that will shortly be available in the UK. This study will determine whether 12-weeks treatment with Lurasidone is associated with reductions in body fat and metabolic indices.